A Minimalist Design Looks Great for Clearing Tau
Interception of Extracellular Tau by Antibodies May Be Sufficient to Stop the Spread of Tau in AD
Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
There are two schools of thought on the “industrialization” of single-use bioprocessing. The camps cannot agree if disposable processing has fully arrived or not. Some believe that disposable processing will not have fully arrived, or been industrialized, until single-use equipment becomes widely available for end-to-end unit operations industry-wide and across production scales. Others say defining industrialization solely in terms of end-to-end disposability neglects the evolution of bioprocessing itself. An industry study cited by Justin Hutchinson, associate director of product management for Thermo Fisher Scientific’s cell culture and bioprocessing business, estimates that more than 40% of integrated single-use systems are now used in GMP manufacturing. Which camp are you in?